Ryo Tsumura
Kashiwa, 2778577, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Peripheral Blood Mononuclear Cell (PBMC) Humanized Mice as a Platform for a Preclinical In Vivo Evaluation of T-Cell-Dependent Bispecific Antibodies.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 10, 2026
Measurement of T Cell Migration by T Cell-Dependent Bispecific Antibody in Cancer Cells and T Cell Cross-Linking.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 10, 2026
Visualization of Immunological Synapse Formation by Intercellular Cross-Linking of T Cell-Dependent Bispecific Antibodies Using Fluorescence Microscopy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 10, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.
Journal: Molecular pharmaceutics
Published: March 01, 2026
Immunological synapse formation as a key mechanism in T cell-dependent bispecific antibody-mediated immune activation and cytotoxicity.
Journal: Cancer immunology, immunotherapy : CII
Published: December 12, 2024
Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation.
Journal: ACS medicinal chemistry letters
Published: September 15, 2023
Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer.
Journal: Scientific reports
Published: December 28, 2022
Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis.
Journal: Molecular pharmaceutics
Published: December 27, 2022
Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate.
Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate.
Journal: Cancer science
Published: October 23, 2020
Last Updated: 09/26/2026